Mikhail Blagosklonny’s Plan for Oncology

Mikhail Blagosklonny is a researcher, professor, writer, and philanthropist. He is a graduate of the First Palov State Medical Uniersity of Saint Petersburg with an M.D. in Internal Medicine as well as a PhD in Experimental Medicine and Cardiology. He was a Professor of Medicine in New York Medical College until 2002. He is currently based in Roswell Park Cancer Institute as a professor of Oncology since 2009. Before this, he was a senior scientist at Ordway Research Institute in Albany, New York. He is an editor at Oncotarget, a journal of oncology, where he is specifically responsible for articles related to cell death and differentiation. Blagosklonny has written more than 300 publications to this day and learn more about Mikhail.

Blagosklonny’s passion is the research of cell aging and death and their connection to cancer. Blagosklonny’s goal is to find cancer treatment, which is affordable and easy on the body, unlike modern chemotherapy which is extremely tough for cancer patients to live through and recover from. Finding a medicine, which kills only the cancer cells is a way to reduce the damage to the whole body, as is the case with chemotherapy and read full article.

The main pathway through this is stopping cells from aging and dying. His advancement to this is the discovery of the rapamycin molecule’s effect on the cell cycle. Rapamycin helps stop the cellular pathway of the body from producing cells which cause aging. These aging cells make the cells of the body grow and divide, which ages them. Rapamycin lowers these processes for cancer cells as well which is handling one of the main problems of cancer patients – the rapid growth and division of cancer cells. It works by inhibiting MTOR signaling and stopping cellular senescence. MTOR pathway is activated by hormones, nutrients, growth triggers and oxygen. It thus slows the aging process and extends life span and Mikhail lacrosse camp.

According to him, aging is a systematic hyperfunction of the growth process. Aging is a continuation of cell growth which proves that it is not really a natural program to the body, since growth of the organism should cease when the body reaches its maximum size. Rapamycin stops this program and in this way prevents the threat of possible cancer formations. In the case of an existing cancer formation, rapamycin stops the already began process of cell division and overgrowth. Blagosklonny hopes that, through his findings, future scientists will be able to develop anti-aging medicines, eliminate cancer forever, and maybe even prolong life and more information click here.

More Visit: https://www.linkedin.com/in/mikhail-blagosklonny-91abb531/